stockrowIndivior Pharmaceuticals Inc.
SUPN Healthcare Drug Manufacturers Specialty & Generic
Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024.
- Revenue
- +13.4%
- EPS
- +241.5%
- Free cash flow
- +240.7%
- Total debt
- +51.6%
Quarter to September 2026, against a year earlier
Follow SUPN
Alert me
Indivior Pharmaceuticals Inc. (SUPN) Free cash flow
Indivior Pharmaceuticals Inc.'s free cash flow for fiscal 2025 was −$94.0M, compared with $5.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $31.0M. Over the past ten years it has ranged from −$353.0M (fiscal 2023) to $372.0M (fiscal 2016); the current reading is higher than 27% of that period. Indivior Pharmaceuticals Inc. ranks 27th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$94.0M | — |
| FY2024 | $5.0M | — |
| FY2023 | −$353.0M | — |
| FY2022 | −$9.0M | — |
| FY2021 | $339.0M | — |
| FY2020 | −$197.0M | — |
| FY2019 | $148.0M | (50.50%) |
| FY2018 | $299.0M | 18.65% |
| FY2017 | $252.0M | (32.26%) |
| FY2016 | $372.0M | 28.72% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $83.0M | (62.61%) |
| Jun 2026 | $222.0M | — |
| Mar 2026 | −$29.0M | — |
| Dec 2025 | −$245.0M | — |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | $409.5M |
| ALKS Alkermes plc compare | $228.4M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $197.2M |
| LQDA Liquidia Corporation compare | $150.7M |
| RDY Dr. Reddy's Laboratories Ltd compare | $96.0M |
| HIMS Hims & Hers Health, Inc. compare | $83.0M |
| SUPN Indivior Pharmaceuticals Inc. | $31.0M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −$60.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$130.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on SUPN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement